NewsBenzingaRenovoRx Enrolls First Participant In PRISM-TAMP, “PDAC Regression And Intraoperative Surgical Margin With Neoadjuvant TAMP Study RenovoRx Enrolls First Participant In PRISM-TAMP, “PDAC Regression And Intraoperative Surgical Margin With Neoadjuvant TAMP Study Benzinga 2026.10.07 12:35 (GMT+0) Open on Benzinga Other news 'Europe’s Top Carriers Explore Satellite Group to Fend Off SpaceX' - Bloomberg HC Wainwright & Co. Reiterates Buy on Zentalis Pharmaceuticals, Maintains $10 Price Target Reported October 16, 'CFP reaches 'handshake agreement' with ESPN to air 24-team playoff, sources say' - ESPN HC Wainwright & Co. Maintains Buy on Enliven Therapeutics, Raises Price Target to $73 Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target AI Boom Hits a Power Wall: Microsoft Walks Away From Nscale's UK Data Center Deal
Reported October 16, 'CFP reaches 'handshake agreement' with ESPN to air 24-team playoff, sources say' - ESPN
